Pharmaceutical failure-to-warn litigation revolves around the concern that a drug manufacturer did not adequately communicate a known risk that was associated with the use of its product. In a case of this nature, the patient experiencing a serious complication after taking the medication in question is not enough. The existence of an injury alone does […]
Life care plans ask a poignant question: What are the long-term cost projections of medical, rehabilitative, and supportive care for an injured individual following a catastrophic injury? In litigation, life care plans are not a generalized estimate for future hardship. Instead, they function as evidentiary frameworks used to quantify future medical damages through structured analysis […]
There are many catastrophic injury cases where the injury itself is not placed as the primary dispute. Medical imaging may confirm spinal damage, traumatic brain injury, fractures, or internal trauma with little disagreement regarding the diagnosis. Litigation, however, focuses on the mechanism: how the injury occurred, whether the forces involved were sufficient to produce the […]
Product liability litigation frequently centers on whether a product was defectively designed, inadequately labeled, or unreasonably dangerous during ordinary use. However, the dispute is not limited to the physical characteristics of the product itself. The analysis also focuses on how real people interact with products under actual conditions rather than idealized assumptions. As such, human […]
Clinical guidelines play an important role in medical care and modern litigation. Professional organizations, specialty boards, hospital systems, and public health agencies regularly publish recommendations intended to guide diagnosis, treatment, monitoring, and risk management across a wide range of medical conditions and procedures. In malpractice litigation, these materials are often introduced as evidence supporting […]